443 related articles for article (PubMed ID: 26478006)
61. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.
Jessen B; Maul-Pavicic A; Ufheil H; Vraetz T; Enders A; Lehmberg K; Längler A; Gross-Wieltsch U; Bay A; Kaya Z; Bryceson YT; Koscielniak E; Badawy S; Davies G; Hufnagel M; Schmitt-Graeff A; Aichele P; Zur Stadt U; Schwarz K; Ehl S
Blood; 2011 Oct; 118(17):4620-9. PubMed ID: 21878672
[TBL] [Abstract][Full Text] [Related]
62. Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome.
Zarzour W; Kleta R; Frangoul H; Suwannarat P; Jeong A; Kim SY; Wayne AS; Gunay-Aygun M; White J; Filipovich AH; Gahl WA
Mol Genet Metab; 2005 Jun; 85(2):125-32. PubMed ID: 15896657
[TBL] [Abstract][Full Text] [Related]
63. Biochemical studies on the leukocytes in Chediak-Higashi syndrome.
Zabucchi G; Cramer R; Soranzo MR; Tamaro P; Panizon F
Acta Haematol; 1977; 58(1):50-7. PubMed ID: 199018
[TBL] [Abstract][Full Text] [Related]
64. A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity.
Cui SH; Tanabe F; Terunuma H; Iwatani Y; Nunoi H; Agematsu K; Komiyama A; Nomura A; Hara T; Onodera T; Iwata T; Ito M
Clin Exp Immunol; 2001 Aug; 125(2):283-90. PubMed ID: 11529921
[TBL] [Abstract][Full Text] [Related]
65. On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.
Zhao H; Boissy YL; Abdel-Malek Z; King RA; Nordlund JJ; Boissy RE
Lab Invest; 1994 Jul; 71(1):25-34. PubMed ID: 8041115
[TBL] [Abstract][Full Text] [Related]
66. Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking.
Huizing M; Anikster Y; Gahl WA
Thromb Haemost; 2001 Jul; 86(1):233-45. PubMed ID: 11487012
[TBL] [Abstract][Full Text] [Related]
67. Periodontitis in Chédiak-Higashi Syndrome: An Altered Immunoinflammatory Response.
Thumbigere Math V; Rebouças P; Giovani PA; Puppin-Rontani RM; Casarin R; Martins L; Wang L; Krzewski K; Introne WJ; Somerman MJ; Nociti FH; Kantovitz KR
JDR Clin Trans Res; 2018 Jan; 3(1):35-46. PubMed ID: 29276776
[TBL] [Abstract][Full Text] [Related]
68. Cloning of bovine LYST gene and identification of a missense mutation associated with Chediak-Higashi syndrome of cattle.
Kunieda T; Nakagiri M; Takami M; Ide H; Ogawa H
Mamm Genome; 1999 Dec; 10(12):1146-9. PubMed ID: 10594238
[TBL] [Abstract][Full Text] [Related]
69. Establishment of a set of combined immunodeficient DA/Slc-Foxn1(rnu) Lyst(bg) congenic rat strains.
Masui N; Nishikawa T; Takagi Y; Kimura H; Mori M; Yokose S; Asai H; Gonda T; Yanabe M; Sato K
Exp Anim; 2004 Oct; 53(5):399-407. PubMed ID: 15516787
[TBL] [Abstract][Full Text] [Related]
70. Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.
Phatarpekar PV; Billadeau DD
J Cell Sci; 2020 Feb; 133(5):. PubMed ID: 32086255
[TBL] [Abstract][Full Text] [Related]
71. Abnormal down-regulation of PKC is responsible for giant granule formation in fibroblasts from CHS (beige) mice--a thiol proteinase inhibitor, E-64-d, prevents giant granule formation in beige fibroblasts.
Tanabe F; Cui SH; Ito M
J Leukoc Biol; 2000 May; 67(5):749-55. PubMed ID: 10811017
[TBL] [Abstract][Full Text] [Related]
72. L is for lytic granules: lysosomes that kill.
Page LJ; Darmon AJ; Uellner R; Griffiths GM
Biochim Biophys Acta; 1998 Feb; 1401(2):146-56. PubMed ID: 9531970
[TBL] [Abstract][Full Text] [Related]
73. Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein.
Karim MA; Nagle DL; Kandil HH; Bürger J; Moore KJ; Spritz RA
Hum Mol Genet; 1997 Jul; 6(7):1087-9. PubMed ID: 9215679
[TBL] [Abstract][Full Text] [Related]
74. Beige rat: a new animal model of Chediak-Higashi syndrome.
Nishimura M; Inoue M; Nakano T; Nishikawa T; Miyamoto M; Kobayashi T; Kitamura Y
Blood; 1989 Jul; 74(1):270-3. PubMed ID: 2752114
[TBL] [Abstract][Full Text] [Related]
75. Regulation of secretory granule size by the precise generation and fusion of unit granules.
Hammel I; Lagunoff D; Galli SJ
J Cell Mol Med; 2010 Jul; 14(7):1904-16. PubMed ID: 20406331
[TBL] [Abstract][Full Text] [Related]
76. Enhanced diacylglycerol production by phospholipase D activation is responsible for abnormal increase in concanavalin A cap formation in polymorphonuclear leukocytes from Chediak-Higashi syndrome (beige) mice.
Kasai H; Tanabe F
Int Immunopharmacol; 2014 Jul; 21(1):193-9. PubMed ID: 24830864
[TBL] [Abstract][Full Text] [Related]
77. Infantile hemophagocytic lymphohistiocytosis in a case of chediak-higashi syndrome caused by a mutation in the LYST/CHS1 gene presenting with delayed umbilical cord detachment and diarrhea.
Nielsen C; Agergaard CN; Jakobsen MA; Møller MB; Fisker N; Barington T
J Pediatr Hematol Oncol; 2015 Mar; 37(2):e73-9. PubMed ID: 25551669
[TBL] [Abstract][Full Text] [Related]
78. Genetic analysis in Egyptian patients with Chediak-Higashi syndrome reveals new LYST mutations.
Gomaa NS; Lee JYW; El Sharkawy A; El Chazli YF; Hassab HMA; Doghaim NN; McGrath JA; Onoufriadis A
Clin Exp Dermatol; 2019 Oct; 44(7):814-817. PubMed ID: 30815890
[No Abstract] [Full Text] [Related]
79. UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.
Iizuka Y; Cichocki F; Sieben A; Sforza F; Karim R; Coughlin K; Isaksson Vogel R; Gavioli R; McCullar V; Lenvik T; Lee M; Miller J; Bazzaro M
J Immunol; 2015 Nov; 195(10):4760-70. PubMed ID: 26438524
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
